What Does 'Adenocarcinoma' Mean on a Report?

Adenocarcinoma is cancer that starts in glandular cells. These are cells that line certain organs. They make and release fluids, such as mucus. Because so many organs contain gland cells, adenocarcinoma is one of the most common cancer types overall.

You may see "adenocarcinoma" on a report for cancer of the colon or rectum, lung, breast, pancreas, stomach, esophagus, or prostate, among others. The same word describes cancers in very different organs. That's because it refers to the type of cell involved, not the location.

Under the microscope, adenocarcinoma cells often try to form gland-like structures. Sometimes they even produce mucus, even though the tissue has become cancerous. This pattern is what lets a pathologist call it adenocarcinoma. Squamous cell carcinoma, by contrast, starts in flat, scale-like cells. In organs where more than one cell type is possible, such as the lung or esophagus, this distinction genuinely changes treatment. Some drugs are studied and approved specifically for adenocarcinoma.

The word adenocarcinoma describes the kind of cell the cancer started in. It does not, by itself, tell you the stage, meaning how far it has spread. It does not tell you the grade, meaning how abnormal the cells look. Those details appear elsewhere on your report. They matter a great deal for treatment and outlook.

Cell type shapes which treatments are considered. In lung cancer, several targeted drugs are approved specifically for adenocarcinoma. These are tied to mutations such as EGFR or ALK. These mutations show up more often in this cell type than in squamous lung cancer. In colorectal cancer, adenocarcinoma is by far the most common type. Most standard chemotherapy and targeted regimens were developed and tested specifically in it. Your oncologist builds your treatment plan around cell type together with stage, grade, and biomarker results.

To understand what an adenocarcinoma diagnosis means for you, look at it together with the organ involved, the stage, the grade, and any other markers your report lists. Your care team can walk through how these pieces fit together for your specific situation.

The word "adenocarcinoma" alone does not signal an emergency. What determines urgency is the stage and any symptoms you are having, not the cell type by itself. Staging tests and a treatment plan typically follow within a few weeks of diagnosis.

• Where did my adenocarcinoma start, and what stage is it?
• Does this cell type make me eligible for any targeted therapies?
• What biomarker tests are being run on this sample?
• How soon will staging be complete and a treatment plan set?

Pathologists sometimes break adenocarcinoma into subtypes. This is based on the specific pattern the gland-forming cells make. Lung adenocarcinoma, for example, has several patterns. These include lepidic, acinar, papillary, micropapillary, and solid. Each is linked with somewhat different behavior. Colorectal adenocarcinoma has its own subtypes too. One is a mucinous form. It behaves somewhat differently from the more typical pattern. These subtypes add detail beyond the basic word "adenocarcinoma." Your pathology report may list one, if it applies to your cancer.

Sometimes adenocarcinoma is found somewhere it has spread to. This could be a lymph node or the liver. But there is no clear original site. This is called cancer of unknown primary. Doctors use imaging, IHC staining, and sometimes genomic testing. These help narrow down where the cancer likely started. That guides which treatments are most likely to work. Finding the primary site isn't always possible. Even without it, doctors can often choose a reasonable treatment approach. They base it on how the cancer looks and behaves.

Adenocarcinoma is confirmed through a biopsy. A small tissue sample is removed and examined directly under a microscope. Imaging alone, such as a CT or MRI scan, can suggest cancer is likely. But it cannot reliably tell adenocarcinoma apart from other cell types. It also cannot rule out a benign condition on its own. This is why a biopsy is a required step before starting cancer treatment. This holds true in almost every situation, even when imaging looks highly suspicious by itself.

• SEER Training Modules (National Cancer Institute) — Cancer Classification
• National Cancer Institute — Diagnosis and Staging